Skip to content

Criteria for the successful application of Bioglass S53P4 in chronic osteomyelitis

Criteria for the successful application of Bioglass S53P4 in chronic osteomyelitis - bioglass in chronic osteomyelitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033820
Enrollment
350
Registered
2024-03-06
Start date
2024-01-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M86

Interventions

Group 1: filling of bone defects with bioactive glass in patients with chronic osteomyelitis

Sponsors

BG Klinikum Duisburg gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: bony defect in patients with chronic osteomyelitis

Exclusion criteria

Exclusion criteria: aseptic bony defect

Design outcomes

Primary

MeasureTime frame
bony consolidation

Secondary

MeasureTime frame
control of infection, weight bearing, complications

Countries

Germany

Contacts

Public ContactEva Steinhausen

BG Klinikum Duisburg gGmbH

evasimone.steinhausen@bg-klinikum-duisburg.de+4920376880

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026